325 related articles for article (PubMed ID: 28886887)
1. Making medicine; producing pleasure: A critical examination of medicinal cannabis policy and law in Victoria, Australia.
Lancaster K; Seear K; Ritter A
Int J Drug Policy; 2017 Nov; 49():117-125. PubMed ID: 28886887
[TBL] [Abstract][Full Text] [Related]
2. MEDICINAL CANNABIS LAW REFORM IN AUSTRALIA.
Freckelton I
J Law Med; 2016 Mar; 23(3):497-515. PubMed ID: 27323630
[TBL] [Abstract][Full Text] [Related]
3. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
[TBL] [Abstract][Full Text] [Related]
4. Children as voices and images for medicinal cannabis law reform.
Freckelton Ao Qc I
Monash Bioeth Rev; 2021 Dec; 39(Suppl 1):4-25. PubMed ID: 34719005
[TBL] [Abstract][Full Text] [Related]
5. Building smart cannabis policy from the science up.
Weiss SRB; Howlett KD; Baler RD
Int J Drug Policy; 2017 Apr; 42():39-49. PubMed ID: 28189459
[TBL] [Abstract][Full Text] [Related]
6. Observations of the role of science in the United States medical cannabis state policies: Lessons learnt.
Grbic J; Goddard P; Ryder D
Int J Drug Policy; 2017 Apr; 42():109-114. PubMed ID: 28190671
[TBL] [Abstract][Full Text] [Related]
7. Mapping regulatory models for medicinal cannabis: a matrix of options.
Belackova V; Shanahan M; Ritter A
Aust Health Rev; 2018 Aug; 42(4):403-411. PubMed ID: 28553995
[TBL] [Abstract][Full Text] [Related]
8. Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice.
Lucas P
Int J Drug Policy; 2009 Jul; 20(4):296-303. PubMed ID: 19124233
[TBL] [Abstract][Full Text] [Related]
9. Producing the 'problem of drugs': A cross national-comparison of 'recovery' discourse in two Australian and British reports.
Lancaster K; Duke K; Ritter A
Int J Drug Policy; 2015 Jul; 26(7):617-25. PubMed ID: 25962733
[TBL] [Abstract][Full Text] [Related]
10. Six policy lessons relevant to cannabis legalization.
Shover CL; Humphreys K
Am J Drug Alcohol Abuse; 2019; 45(6):698-706. PubMed ID: 30870053
[No Abstract] [Full Text] [Related]
11. Laws prohibiting peer distribution of injecting equipment in Australia: A critical analysis of their effects.
Lancaster K; Seear K; Treloar C
Int J Drug Policy; 2015 Dec; 26(12):1198-206. PubMed ID: 26118796
[TBL] [Abstract][Full Text] [Related]
12. Does liberalizing cannabis laws increase cannabis use?
Williams J; Bretteville-Jensen AL
J Health Econ; 2014 Jul; 36():20-32. PubMed ID: 24727348
[TBL] [Abstract][Full Text] [Related]
13. Gambling and Cannabis Use: Clinical and Policy Implications.
Winters KC; Whelan JP
J Gambl Stud; 2020 Mar; 36(1):223-241. PubMed ID: 31828696
[TBL] [Abstract][Full Text] [Related]
14. MEDICINAL CANNABIS LAW REFORM: LESSONS FROM CANADIAN LITIGATION.
Freckelton I
J Law Med; 2015 Jun; 22(4):719-38. PubMed ID: 26349373
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based policy? The re-medicalization of cannabis and the role of expert committees in the UK, 1972-1982.
Taylor SL
Int J Drug Policy; 2016 Nov; 37():129-135. PubMed ID: 27477790
[TBL] [Abstract][Full Text] [Related]
16. Medicinal cannabis and driving: the intersection of health and road safety policy.
Perkins D; Brophy H; McGregor IS; O'Brien P; Quilter J; McNamara L; Sarris J; Stevenson M; Gleeson P; Sinclair J; Dietze P
Int J Drug Policy; 2021 Nov; 97():103307. PubMed ID: 34107448
[TBL] [Abstract][Full Text] [Related]
17. Comment on the Central Drug Authority's position statement on cannabis.
Scott K
S Afr Med J; 2016 May; 106(6):20-1. PubMed ID: 27245714
[TBL] [Abstract][Full Text] [Related]
18. Medical Marijuana programs: implications for cannabis control policy--observations from Canada.
Fischer B; Kuganesan S; Room R
Int J Drug Policy; 2015 Jan; 26(1):15-9. PubMed ID: 25287942
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceuticals issue brief: medical marijuana: year end report-2002.
Herstek J; Watson A; Kammer C
Issue Brief Health Policy Track Serv; 2002 Dec; ():1-12. PubMed ID: 12856685
[TBL] [Abstract][Full Text] [Related]
20. A critical examination of the definition of 'psychoactive effect' in Australian drug legislation.
Barratt MJ; Seear K; Lancaster K
Int J Drug Policy; 2017 Feb; 40():16-25. PubMed ID: 27884504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
